In 2024, the US Food and Drug Administration (FDA) approved Wegovy for another indication besides weight loss : to reduce the risk of heart attack, stroke , or death in people with obesity or overweight and established heart disease
Gregorian C, Nakashima J, Dry SM, Nghiemphu PL, Smith KB, Ao Y, et al
Rapid weight loss (or reduced fat mass) can also impact lean mass, bone density, skin/tissue quality, and facial appearance (sometimes noted as hollowing in the face)
So yes, diabetic meds can absolutely work if you want to lose weight
10.1016/j.lfs.2019.117160 Life Sci
Danuglipron, which was discovered and developed in-house at Pfizer, is a type of investigational medicine known as a GLP-1 receptor agonist